Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Virtual drug discovery and development for neglected diseases through public-private partnerships.

Literature DB >> 14668812

Virtual drug discovery and development for neglected diseases through public-private partnerships.

Solomon Nwaka¹, Robert G Ridley.

Abstract

Mesh：

Year: 2003 PMID： 14668812 DOI： 10.1038/nrd1230

Source DB: PubMed Journal: Nat Rev Drug Discov ISSN： 1474-1776 Impact factor: 84.694

Keyword Cloud
Cited

× No keyword cloud information.

50 in total

Review 1. Global phenotypic screening for antimalarials.

Authors: W Armand Guiguemde; Anang A Shelat; Jose F Garcia-Bustos; Thierry T Diagana; Francisco-Javier Gamo; R Kiplin Guy
Journal: Chem Biol Date: 2012-01-27

2. More medicines for neglected and emerging infectious diseases.

Authors: Jack Radisch
Journal: Bull World Health Organ Date: 2007-08 Impact factor: 9.408

3. Public-private partnership as a solution for integrating genetic services into health care of countries with low and middle incomes.

Authors: Florian Meier; Oliver Schöffski; Jörg Schmidtke
Journal: J Community Genet Date: 2012-05-22

4. Social engineering for virtual 'big science' in systems biology.

Authors: Hiroaki Kitano; Samik Ghosh; Yukiko Matsuoka
Journal: Nat Chem Biol Date: 2011-06 Impact factor: 15.040

5. Potential antimalarial activity of Methyl Jasmonate and its effect on lipid profiles in Plasmodium Berghei infected mice.

Authors: Oladapo E Oyinloye; Ayokulehin M Kosoko; Benjamin Emikpe; Catherine O Falade; Olusegun G Ademowo
Journal: Afr Health Sci Date: 2015-09 Impact factor: 0.927

6. Selection of a trioxaquine as an antimalarial drug candidate.

Authors: Frédéric Coslédan; Laurent Fraisse; Alain Pellet; François Guillou; Benjamin Mordmüller; Peter G Kremsner; Alicia Moreno; Dominique Mazier; Jean-Pierre Maffrand; Bernard Meunier
Journal: Proc Natl Acad Sci U S A Date: 2008-11-05 Impact factor: 11.205

Virtual drug discovery and development for neglected diseases through public-private partnerships.

Review 1. Global phenotypic screening for antimalarials.

2. More medicines for neglected and emerging infectious diseases.

3. Public-private partnership as a solution for integrating genetic services into health care of countries with low and middle incomes.

4. Social engineering for virtual 'big science' in systems biology.

5. Potential antimalarial activity of Methyl Jasmonate and its effect on lipid profiles in Plasmodium Berghei infected mice.

6. Selection of a trioxaquine as an antimalarial drug candidate.

7. Development of and access to products for neglected diseases.

8. Advancing drug innovation for neglected diseases-criteria for lead progression.

Review 9. New, improved treatments for Chagas disease: from the R&D pipeline to the patients.

10. A kernel for open source drug discovery in tropical diseases.